Seven Top Pharma Companies Adopt PhaseV’s Machine Learning Technology for Drug Development
Within Two Years of Hitting the Market, PhaseV Solutions are Being Used to Guide Adaptive Trials, Precision Medicine, and Indication...
Year: 2024
Slope and LabConnect Unveil Groundbreaking Bidirectional API Integration for Clinical Trials
First-of-its-kind API integration revolutionizes biospecimen lifecycle management and data integrity RICHMOND, Va. and JOHNSON CITY, Tenn., Nov. 25, 2024 /PRNewswire/...
Semler Scientific® Announces Updated BTC and ATM Activity
- Purchased Additional 297 BTC; Now Holds 1,570 BTC; BTC Yield of 58.4% - - Launches Additional $50.0 million ATM...
CLEARLAKE CAPITAL COMPLETES SALE OF TEAM TECHNOLOGIES
Sale to Arlington Capital Partners Completes Company's Transformation into a Healthcare-focused Specialized Manufacturing and Supply Chain Solutions Provider Under Clearlake...
Jaguar Health Presenting December 3rd at NobleCon20 and December 5th at the Emerging Growth Conference
SAN FRANCISCO, CA / ACCESSWIRE / November 25, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that Lisa Conte, the...
Wellstack Partners With Hartford HealthCare to Advance Data Integration and Healthcare Analytics
Wellstack and Hartford HealthCare Partner to Drive Innovation in Data Integration and Patient-Centered Care MADISON, WILTZ / ACCESSWIRE / November...
Revitalist Releases Benefits Program Giving Access To All for Ketamine Therapies Changing the Narrative of Mental Health to Risk Mitigation
Vancouver, British Columbia--(Newsfile Corp. - November 25, 2024) - Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTC: RVLWF) (FSE: 4DO)...
BioHarvest Launches VINIA SuperFood Functional Tea Line
Incremental Product Launch Addresses $3.3 Billion North American Functional Tea Market Opportunity with First SuperFood Tea Infused with Piceid ResveratrolVancouver,...
Neurotech Innovator UNEEG Medical Receives FDA Breakthrough Device Designation Within Monitoring and Diagnostic of Epilepsy
The designation is a result of UNEEG's strong focus on developing novel disease management support tools with transformational and first-to-market...
Lexaria’s GLP-1 Human Pilot Study #3 Completes Dosing as Scheduled
DehydraTECH-processed tirzepatide from Zepbound® is being tested in an oral dose format KELOWNA, BC / ACCESSWIRE / November 25, 2024...
CNS Pharmaceuticals Presents Update from Ongoing Potentially Pivotal Study of Berubicin Compared with Lomustine in Adult Patients with Recurrent GBM (WHO Grade IV) After Failure of Standard First Line Therapy
Poster presented at the 29th Annual Meeting of the Society for Neuro-Oncology (SNO 2024)Primary analysis data in potentially pivotal GBM...
S4 Medical Receives FDA 510(k) Approval for its Redesigned Esophageal Deviation Device and Begins Commercialization
CHAGRIN FALLS, OH / ACCESSWIRE / November 25, 2024 / S4 Medical Corp, an Ohio based company committed to making...
Acreage Provides Update on Corporate Transactions
NEW YORK, NY / ACCESSWIRE / November 25, 2024 / Acreage Holdings, Inc. ("Acreage" or the "Company") (CSE:ACRG.A.U, ACRG.B.U)(OTCQX:ACRHF, ACRDF),...
Moderna to Present at Upcoming Conferences in December 2024
CAMBRIDGE, MA / ACCESSWIRE / November 25, 2024 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming...
Teladoc Health Expands AI Capabilities for Hospitals and Health Systems with Advanced Virtual Sitter Solution
New artificial intelligence (AI) capabilities help hospitals and health systems deliver safer and more efficient care Teladoc Health's AI-enabled Virtual...
MDxHealth to Participate in Piper Sandler Healthcare Conference
MDxHealth to Participate in Piper Sandler Healthcare Conference IRVINE, CA – November 25, 2024 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH)...
Spinogenix Appoints American Football Hall of Famer and Health Advocate Steve Young to its Board of Directors
LOS ANGELES, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Spinogenix, Inc., a clinical-stage biopharmaceutical company pioneering first-in-class therapeutics that restore synapses...
QHSLab, Inc. (OTCQB: USAQ) Marks Major Achievements in Digital Health Innovation, Research Recognition, and Revenue Growth in 2024
Revenue Growth and APA Recognition Drive Momentum for QHSLab in 2024 WEST PALM BEACH, FL, Nov. 25, 2024 (GLOBE NEWSWIRE)...
Xenon to Showcase New Long-Term Azetukalner Data at AES 2024
Five posters to be presented including new long-term 36-month data from the ongoing X-TOLE OLE study of azetukalner in FOS...
Tenaya Therapeutics Doses First Patient in RIDGE™-1 Phase 1b Clinical Trial of TN-401 for the Treatment of PKP2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy
TN-401 AAV9-based Gene Therapy Designed to Deliver Fully Functional PKP2 Gene with the Aim of Increasing Protein Levels to Address...